Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce childhood mortality; however, more ...

BACKGROUND: There are conflicting findings from observational studies of the arrhythrogenic potential of azithromycin. Our aim was to quantify the association between azithromycin use and the risk of ...

Azithromycin (U Rom (500mg)) is a macrolide antibiotic used for various bacterial infections such as infections of the middle ear, throat, bronchus, sinuses, skin and soft tissue. It is also useful in ...

The aim of the study was to use real-world data to compare the risk of cardiac events in new users of azithromycin vs amoxicillin. Azithromycin does not appear to increase the risk of cardiac events ...

NEW YORK CITY — Treatment guidelines increasingly recommend that certain antibiotics, particularly the macrolide azithromycin, no longer be used to treat many common infections. Inappropriate use has ...

Please provide your email address to receive an email when new articles are posted on . Azithromycin treatment correlated with a higher risk of sudden cardiac death. Lowering the potassium gradient ...

The popular antibiotic azithromycin (Zithromax and Zmax, Pfizer) poses the risk for a potentially fatal irregular heart rhythm, which therefore warrants careful screening of patients for this drug, ...

Azithromycin (F Zit (250mg)) is a macrolide antibiotic used for various bacterial infections such as infections of the middle ear, throat, bronchus, sinuses, skin and soft tissue. It is also useful in ...

Single-dose azithromycin is the first-choice antibiotic for the treatment of trachoma. The World Health Organization (WHO) currently recommends annual mass azithromycin treatment for 3 years in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Azithromycin may increase risk for acute HF and ...